Financials in CAD. Standardized financial statements.
A compact view of how Solarvest BioEnergy Inc. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1,026 | $2,153 | $0 | $0 | $0 | $0 | $0 | $0 | $1,675 | $0 |
| Revenue Growth? | -52.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -100.0% | 0.0% | 0.0% |
| Cost of Revenue? | $1,404 | $1,889 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit? | -$378 | $264 | $0 | $0 | $0 | $0 | $0 | $0 | $1,675 | $0 |
| Gross Margin? | -36.8% | +12.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | +100.0% | 0.0% |
| Operating Expenses? | $1.54M | $2.38M | $1.52M | $1.32M | $1.00M | $907,913 | $1.65M | $1.68M | $1.53M | $1.19M |
| Operating Income? | -$1.63M | -$2.50M | -$1.63M | -$1.35M | -$1.02M | -$923,955 | -$1.66M | -$1.69M | -$1.55M | -$1.19M |
| EBITDA? | -$1.45M | -$3.27M | -$1.46M | -$1.21M | -$1.06M | -$714,686 | -$1.44M | -$1.46M | -$1.32M | -$1.04M |
| Income Before Tax | -$1.63M | -$3.46M | -$1.54M | -$1.39M | -$1.27M | -$916,127 | -$1.57M | -$1.48M | -$951,174 | -$692,322 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $8,389 | $5,942 | $6,685 | $6,213 |
| Net Income? | -$1.63M | -$3.46M | -$1.54M | -$1.39M | -$1.27M | -$916,127 | -$1.57M | -$1.48M | -$951,174 | -$692,322 |
| EPS? | $-0.03 | $-0.07 | $-0.04 | $-0.05 | $-0.06 | $-0.04 | $-0.07 | $-0.08 | $-0.06 | $-0.06 |
| Diluted EPS? | $-0.03 | $-0.07 | $-0.04 | $-0.05 | $-0.06 | $-0.04 | $-0.07 | $-0.07 | $-0.06 | $-0.06 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality